Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

IBCSG 19-01 

Phase III randomised double blind study of Letrozole versus placebo in women with primary breast cancer completing five or more years of adjuvant Tamoxifen

DESIGN

Design Trial 19-01

Results & Publications


Publications

Study Chair
Prof. Monica Castiglione - Bern, Switzerland

Trial Coordinator
Rita Pfister
IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 511 94 00
Fax: +41 31 511 94 01
Email: rita.pfister@ibcsg.org

Date of Activation
September 3, 2001

Date of Closure
May 31, 2002

Targeted Accrual
4800 patients

Final Accrual
5031 patients


Results Publications Results & Publications


News

21.06.2017:
IBCSG Slide Deck ASCO 2017 available now

15.06.2017:
PINK GOLF TOUR 2017 für die Brustkrebs-Prävention  

11.06.2017:
Frauenlauf 2017

All News

 
  Print